Daplyza™

  • All Products
  • By Generic
  • By Therapeutic Segment

Daplyza™

Therapeutic Segment: Anti-Diabetic

Generic Name: Dapagliflozin

Indication:

Daplyza (Dapagliflozin) is indicated for:

  • As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
  • To reduce the risk of hospitalization for heart failure in adults with type 2 diabetes mellitus and either established cardiovascular disease or multiple cardiovascular risk factors.
  • To reduce the risk of cardiovascular death and hospitalization for heart failure in adults with heart failure (NYHA class II-IV) with reduced ejection fraction.
  • To reduce the risk of sustained eGFR decline, end-stage kidney disease, cardiovascular death and hospitalization for heart failure in adults with chronic kidney disease at risk of progression.

Available as:

Tablet
  • 5mg
  • 10MG

Buy our products online.

Making lives easier, healthier, happier.

Click to Order Online